<?xml version="1.0" encoding="UTF-8"?>
<p>Data from MERS-CoV, which broke out in 2012 in Saudi Arabia, showed that the severity and length of the pulmonary pathology observed were increased in those affected by type 2 diabetes, which likely deregulates immune response (
 <xref rid="B6" ref-type="bibr">6</xref>). Data on COVID-19 in patients with diabetes is limited at present (
 <xref rid="B5" ref-type="bibr">5</xref>). The Chinese Centre for Disease Control and Prevention published a report of 72,314 cases of COVID-19, showing an increased mortality rate in subjects with diabetes (
 <xref rid="B7" ref-type="bibr">7</xref>).
</p>
